Bruce Pyenson

Summary

Affiliation: Milliman USA
Country: USA

Publications

  1. ncbi An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost
    Bruce S Pyenson
    Milliman, New York City, New York, USA
    Health Aff (Millwood) 31:770-9. 2012
  2. ncbi MAKING THE CASE FOR Biotechnology Reinsurance (BIO-RE)
    Bruce Pyenson
    is a principal and a consulting actuary at Milliman Inc, in New York He can be reached by e mail at or by phone at 646 473 3201
    Biotechnol Healthc 5:31-5. 2008

Collaborators

Detail Information

Publications2

  1. ncbi An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost
    Bruce S Pyenson
    Milliman, New York City, New York, USA
    Health Aff (Millwood) 31:770-9. 2012
    ..We also believe that payers and patients should demand screening from high-quality, low-cost providers, thus helping set an example of efficient system innovation...
  2. ncbi MAKING THE CASE FOR Biotechnology Reinsurance (BIO-RE)
    Bruce Pyenson
    is a principal and a consulting actuary at Milliman Inc, in New York He can be reached by e mail at or by phone at 646 473 3201
    Biotechnol Healthc 5:31-5. 2008
    ..The author proposes a combined cost-management and care-delivery standard that could lessen that threat...